No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19
JMIRx Med 2020;1(1):e19583
Go back to the top of the top articles page
Skip top articles and go to footer section
| 1005 | 8 | 1 | |
A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study
JMIRx Med 2020;1(1):e23582
Go back to the top of the top articles page
Skip top articles and go to footer section
| 782 | 58 | 0 | |
Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24453
Go back to the top of the top articles page
Skip top articles and go to footer section
| 186 | 0 | 0 | |
Authors’ Response to Peer Reviews of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24485
Go back to the top of the top articles page
Skip top articles and go to footer section
| 186 | 0 | 0 | |
Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24481
Go back to the top of the top articles page
Skip top articles and go to footer section
| 152 | 0 | 0 | |
Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24747
Go back to the top of the top articles page
Skip top articles and go to footer section
| 90 | 1 | 0 | |
Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study
JMIRx Med 2020;1(1):e22470
Go back to the top of the top articles page
Skip top articles and go to footer section
| 88 | 2 | 2 | |
Author Response to Peer Reviews of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24739
Go back to the top of the top articles page
Skip top articles and go to footer section
| 68 | 1 | 0 | |
Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24765
Go back to the top of the top articles page
Skip top articles and go to footer section
| 64 | 1 | 0 | |
Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis
JMIRx Med 2021;2(1):e22195
Go back to the top of the top articles page
Skip top articles and go to footer section
| 59 | 8 | 3 | |
Author’s Response to Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”
JMIRx Med 2020;1(1):e25573
Go back to the top of the top articles page
Skip top articles and go to footer section
| 53 | 1 | 0 | |
Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”
JMIRx Med 2020;1(1):e25572
Go back to the top of the top articles page
Skip top articles and go to footer section
| 43 | 1 | 0 | |
Authors’ Response to Peer Reviews of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27258
Go back to the top of the top articles page
Skip top articles and go to footer section
| 32 | 1 | 0 | |
Peer Review of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27103
Go back to the top of the top articles page
Skip top articles and go to footer section
| 22 | 1 | 1 | |
Peer Review of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27257
Go back to the top of the top articles page
Skip top articles and go to footer section
| 18 | 1 | 1 | |
A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study
JMIRx Med 2021;2(1):e22617
Go back to the top of the top articles page
Skip top articles and go to footer section
| 4 | 3 | 3 | |
Peer Review of “A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study”
JMIRx Med 2021;2(1):e27536
Go back to the top of the top articles page
Skip top articles and go to footer section
| 3 | 1 | 1 | |
Peer Review of “A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study”
JMIRx Med 2021;2(1):e27260
Go back to the top of the top articles page
Skip top articles and go to footer section
| 3 | 1 | 1 | |
Peer Review of "Are We Sure We Fully Understand What an Infodemic Is? A Global Perspective on Infodemiological Problems"
JMIRx Med 2022;3(3):e40303
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
Peer Review of “Representing Physician Suicide Claims as Nanopublications: Proof-of-Concept Study Creating Claim Networks”
JMIRx Med 2022;3(3):e39889
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
Peer Review of “Exploring the Reasons for Low Cataract Surgery Uptake Among Patients Detected in a Community Outreach Program in Cameroon: Focused Ethnographic Mixed Methods Study”
JMIRx Med 2022;3(2):e38872
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
Authors' Responses to Peer Reviews of “Supporting Technologies for COVID-19 Prevention: Systemized Review”
JMIRx Med 2022;3(2):e38693
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
Peer Review of “The Influence of SARS-CoV-2 Variants on National Case-Fatality Rates: Correlation and Validation Study”
JMIRx Med 2022;3(2):e38547
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
Peer Review of “Using Structural Equation Modelling in Routine Clinical Data on Diabetes and Depression: Observational Cohort Study”
JMIRx Med 2022;3(2):e38007
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
Peer Review of “Mask Use to Curtail Influenza in a Post–COVID-19 World: Modeling Study”
JMIRx Med 2022;3(2):e37240
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |